Traws Pharma, Inc. Shares Outstanding (Cover Page)
Traws Pharma, Inc. (TRAW) had Shares Outstanding (Cover Page) of 15.37 million shares as of 2026-08-12, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-14
- 2026-08-12: Entity Common Stock, Shares Outstanding 15.37M shares.
- 2026-05-12: Entity Common Stock, Shares Outstanding 15.15M shares.
- 2026-04-24: Entity Common Stock, Shares Outstanding 15.15M shares.
- 2026-04-13: Entity Common Stock, Shares Outstanding 10.16M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-12 | 15.37M shares 10-Q · filed 2026-08-14 |
| 2026-05-12 | 15.15M shares 10-Q · filed 2026-05-15 |
| 2026-04-24 | 15.15M shares 10-K/A · filed 2026-04-30 |
| 2026-04-13 | 10.16M shares 10-K · filed 2026-04-15 |
| 2025-11-10 | 7.99M shares 10-Q · filed 2025-11-13 |
| 2025-08-12 | 7.06M shares 10-Q · filed 2025-08-14 |
| 2025-05-13 | 5.56M shares 10-Q · filed 2025-05-15 |
| 2025-04-28 | 5.33M shares 10-K/A · filed 2025-04-30 |
| 2025-03-26 | 5.07M shares 10-K · filed 2025-03-31 |
| 2024-11-11 | 3.03M shares 10-Q · filed 2024-11-14 |
| 2024-08-01 | 25.31M shares 10-Q · filed 2024-08-15 |
| 2024-05-01 | 25.30M shares 10-Q · filed 2024-05-15 |
| 2024-04-15 | 25.30M shares 10-K/A · filed 2024-04-29 |
| 2024-03-01 | 21.04M shares 10-K · filed 2024-04-01 |
| 2023-11-01 | 21.00M shares 10-Q · filed 2023-11-14 |
| 2023-08-01 | 20.98M shares 10-Q · filed 2023-08-14 |
| 2023-05-01 | 20.97M shares 10-Q · filed 2023-05-15 |
| 2023-03-01 | 20.97M shares 10-K/A · filed 2023-05-01 |
| 2022-11-01 | 20.93M shares 10-Q · filed 2022-11-14 |
| 2022-08-01 | 20.90M shares 10-Q · filed 2022-08-15 |
| 2022-05-02 | 20.90M shares 10-Q · filed 2022-05-13 |
| 2022-03-01 | 20.90M shares 10-K/A · filed 2022-04-29 |
| 2021-11-01 | 20.89M shares 10-Q · filed 2021-11-15 |
| 2021-08-04 | 15.78M shares 10-Q · filed 2021-08-16 |
| 2021-05-01 | 236.71M shares 10-Q · filed 2021-05-17 |
| 2021-03-01 | 236.61M shares 10-K · filed 2021-03-18 |
| 2020-11-05 | 184.95M shares 10-Q · filed 2020-11-16 |
| 2020-08-03 | 179.65M shares 10-Q · filed 2020-08-12 |
| 2020-05-01 | 168.67M shares 10-Q · filed 2020-05-15 |
| 2020-03-01 | 167.26M shares 10-K · filed 2020-03-27 |
| 2019-11-01 | 8.20M shares 10-Q · filed 2019-11-12 |
| 2019-08-01 | 6.00M shares 10-Q · filed 2019-08-14 |
| 2019-05-01 | 5.90M shares 10-Q · filed 2019-05-15 |
| 2019-03-01 | 5.90M shares 10-K · filed 2019-04-01 |
| 2018-11-01 | 5.67M shares 10-Q · filed 2018-11-14 |
| 2018-08-01 | 85.11M shares 10-Q · filed 2018-08-14 |
| 2018-05-07 | 77.61M shares 10-Q · filed 2018-05-15 |
| 2018-03-01 | 18.95M shares 10-K · filed 2018-03-16 |
| 2017-10-31 | 9.85M shares 10-Q · filed 2017-11-09 |
| 2017-07-31 | 9.85M shares 10-Q · filed 2017-08-14 |
| 2017-04-30 | 9.49M shares 10-Q · filed 2017-05-15 |
| 2017-03-20 | 6.77M shares 10-K · filed 2017-03-29 |
| 2016-11-08 | 6.76M shares 10-Q · filed 2016-11-14 |
| 2016-08-10 | 6.34M shares 10-Q · filed 2016-08-15 |
| 2016-04-30 | 27.40M shares 10-Q · filed 2016-05-11 |
| 2016-03-15 | 27.40M shares 10-K · filed 2016-03-28 |
| 2015-10-30 | 24.87M shares 10-Q · filed 2015-11-12 |
| 2015-07-31 | 21.79M shares 10-Q · filed 2015-08-13 |
| 2015-04-30 | 21.70M shares 10-Q · filed 2015-05-15 |
| 2015-03-18 | 21.70M shares 10-K · filed 2015-03-30 |
| 2014-10-31 | 21.69M shares 10-Q · filed 2014-11-14 |
| 2014-07-31 | 21.69M shares 10-Q · filed 2014-08-14 |
| 2014-04-30 | 21.64M shares 10-Q · filed 2014-05-15 |
| 2014-02-28 | 21.64M shares 10-K · filed 2014-03-20 |
| 2013-10-31 | 21.41M shares 10-Q · filed 2013-11-14 |
| 2013-08-30 | 21.40M shares 10-Q · filed 2013-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |